[使用肉毒毒素治疗 Bruxism:再考虑一下!]
Nederlands tijdschrift voor tandheelkunde
|July 8, 2024
概括
根据Lobbezoo等的说法,肉毒毒素不是布鲁克斯症 (牙磨牙/紧) 的首要治疗方法. 他们认为这应该是最后的手段,强调由于安全问题和过时的观点而需要谨慎.
科学领域:
- 牙科 牙科是指牙科的专业.
- 面部或面部疼痛和功能障碍
背景情况:
- 牙磨牙和关节紧张的 Bruxism 是一个越来越令人担忧的问题.
- 最近的出版物建议使用肉毒毒素作为重症 Bruxism 的首要治疗方法.
- 然而,这些观点可能基于过时的信息,可能错误地分类了肉毒素的安全性.
研究的目的:
- 为了呈现当前对布鲁克斯主义的见解.
- 为布鲁克斯症概述临床评估方法.
- 讨论治疗策略和肉毒毒素的特定作用.
主要方法:
- 这是Vision的文章,介绍了专家的意见和当前的理解.
- 它回顾了与 Bruxism 相关的现有文献和临床实践.
- 作者分析了肉毒毒素作为 Bruxism 治疗方法的适用性.
主要成果:
- 作者质疑肉毒毒素作为 Bruxism 的一线治疗方法的概念.
- 他们强调,目前一些出版物对布鲁克斯主义的看法已经过时了.
- 建议肉毒毒素是治疗面膜疼痛和功能障碍的终极避难所.
结论:
- 洛贝佐和其他人Lobbezoo等人. 建议谨慎使用肉毒毒素治疗 Bruxism 的方法.
- 他们主张在这种情况下彻底重新评估其安全性和有效性.
- 作者强调,在使用肉毒毒素治疗牛症之前,需要"两次思考".
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
666
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
666
Skeletal Muscle Relaxants: Therapeutic Uses
479
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
479
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
406
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
406
Depolarizing Blockers: Pharmocokinetics
317
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
317


